NCT05028881View on ClinicalTrials.gov

COVID-19 Serology in People Living with HIV in Hong Kong

CompletedOBSERVATIONAL
Enrollment

488

Participants

Timeline

Start Date

May 16, 2020

Primary Completion Date

May 15, 2024

Study Completion Date

November 15, 2024

Conditions
HIV InfectionsSARS-CoV-2 InfectionVaccination; Infection
Interventions
OTHER

blood sampling

blood sampling for determining antibody responses

Trial Locations (1)

0000

Shui Shan Lee, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT05028881 - COVID-19 Serology in People Living with HIV in Hong Kong | Biotech Hunter | Biotech Hunter